• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受直接经皮冠状动脉介入治疗的心肌梗死溶栓治疗III级血流患者的发生率:并非所有罪犯血管在ST段抬高型心肌梗死中均完全闭塞。

Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction.

作者信息

Hussain Muhammad, Kumar Rajesh, Ammar Ali, Alishan Syed, Muhammad Atif S, Farooq Fawad, Saghir Tahir, Khan Naveedullah, Hassan Rizvi Syed N, Ashraf Tariq

机构信息

Interventional Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Adult Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

出版信息

Cureus. 2020 Dec 12;12(12):e12036. doi: 10.7759/cureus.12036.

DOI:10.7759/cureus.12036
PMID:33457136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7797447/
Abstract

Background ST elevation myocardial infarction (STEMI) is classically characterized by total occlusion of the culprit coronary artery. However during primary percutaneous coronary intervention (PCI) thrombolysis in myocardial infarction (TIMI) 0 flow is not observed in all patients' culprit arteries in angiographic views. This study was conducted to find out the frequency of TIMI flow in acute STEMI patients in view of the above concept. The aim of this study was to evaluate the frequency of pre-procedural TIMI III flow in those patients who underwent primary PCI for acute STEMI in a public sector hospital in Karachi, Pakistan. Methodology This study is an audit of already saved data in the catheterization laboratory of the National Institute of Cardiovascular Diseases (NICVD), Karachi, that was collected prospectively from January 2016 to December 2018. These data were collected after taking consent from those patients who presented to hospital within 12 hours of symptoms and underwent primary PCI. Data were entered and analyzed on Statistical Package for the Social Sciences (SPSS) version 19 (IBM Corp., Armonk, NY, USA). Results A total of 8018 patients were included in this study who presented with STEMI and underwent primary PCI. Out of them 80.9% were males. Hypertension was the leading risk factor in 54.1% (4340) of patients. TIMI III flow was present in 11.4% of patients before primary PCI, while TIMI 0, I and II flow were present in 57.1%, 15.1%, and 16.3% of patients respectively (p<0.001). Fourteen percent of patients with TIMI III flow were of age group 51 to 60 years. Among those who had TIMI III flow, 11.2% were those with door to balloon time of <90 minutes. In 11% of cases, left anterior descending (LAD) artery had TIMI III flow as compared to other vessels (p<0.001). The length of the lesion was significantly smaller in patients who had TIMI III flow compared to those who had TIMI 0-II flow. Conclusions This study revealed that not all patients with acute STEMI had totally occluded culprit coronary artery but some of them had angiographic TIMI I-III flow in the infarct-related artery. Further studies are needed to find the reason for re-establishment of flow in the culprit vessel in STEMI patients before PCI.

摘要

背景 ST段抬高型心肌梗死(STEMI)的典型特征是罪犯冠状动脉完全闭塞。然而,在直接经皮冠状动脉介入治疗(PCI)期间,血管造影显示并非所有患者的罪犯动脉均出现心肌梗死溶栓治疗(TIMI)0级血流。鉴于上述概念,本研究旨在了解急性STEMI患者中TIMI血流的发生率。本研究的目的是评估在巴基斯坦卡拉奇一家公立医院接受急性STEMI直接PCI治疗的患者中,术前TIMI Ⅲ级血流的发生率。方法 本研究是对卡拉奇国家心血管疾病研究所(NICVD)导管实验室中已保存数据的审核,这些数据是在2016年1月至2018年12月期间前瞻性收集的。这些数据是在征得那些症状出现后12小时内入院并接受直接PCI治疗的患者同意后收集的。数据录入社会科学统计软件包(SPSS)19版(美国纽约州阿蒙克市IBM公司)并进行分析。结果 本研究共纳入8018例表现为STEMI并接受直接PCI治疗的患者。其中80.9%为男性。高血压是54.1%(4340例)患者的主要危险因素。直接PCI术前11.4%的患者存在TIMIⅢ级血流,而TIMI 0级、Ⅰ级和Ⅱ级血流分别存在于57.1%、15.1%和16.3%的患者中(p<0.001)。14%TIMIⅢ级血流的患者年龄在51至60岁之间。在那些有TIMIⅢ级血流的患者中,11.2%是门球时间<90分钟的患者。与其他血管相比,11%的病例中左前降支(LAD)动脉有TIMIⅢ级血流(p<0.001)。与TIMI 0 - Ⅱ级血流的患者相比,TIMIⅢ级血流的患者病变长度明显较短。结论 本研究表明,并非所有急性STEMI患者的罪犯冠状动脉都完全闭塞,其中一些患者梗死相关动脉存在血管造影TIMIⅠ - Ⅲ级血流。需要进一步研究以找出STEMI患者PCI术前罪犯血管血流重建的原因。

相似文献

1
Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction.接受直接经皮冠状动脉介入治疗的心肌梗死溶栓治疗III级血流患者的发生率:并非所有罪犯血管在ST段抬高型心肌梗死中均完全闭塞。
Cureus. 2020 Dec 12;12(12):e12036. doi: 10.7759/cureus.12036.
2
[Impact of inflammatory reaction levels and culprit plaque characteristics on preprocedural thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction].[炎症反应水平及罪犯斑块特征对ST段抬高型心肌梗死患者术前溶栓后心肌梗死血流分级的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Feb 24;49(2):150-157. doi: 10.3760/cma.j.cn112148-20200531-00452.
3
Prognostic impact of pre-interventional culprit artery thrombolysis in myocardial infarction (TIMI) flow in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.原发性经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者中,介入前罪犯血管心肌梗死溶栓(TIMI)血流的预后影响
Egypt Heart J. 2022 Jun 27;74(1):52. doi: 10.1186/s43044-022-00289-3.
4
Effect of high-intensity statin preloading on TIMI flow in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.高强度他汀预负荷对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者心肌灌注分级血流的影响。
Egypt Heart J. 2020 Jul 10;72(1):40. doi: 10.1186/s43044-020-00074-0.
5
Comparison of angiographic results and clinical outcomes of no-reflow after stenting in left anterior descending (LAD) versus non-LAD culprit STEMI.左前降支(LAD)与非LAD罪犯血管ST段抬高型心肌梗死(STEMI)支架置入术后无复流的血管造影结果与临床结局比较
SAGE Open Med. 2022 Mar 31;10:20503121221088106. doi: 10.1177/20503121221088106. eCollection 2022.
6
Relationship between infarct artery location, acute total coronary occlusion, and mortality in STEMI and NSTEMI patients.STEMI 和 NSTEMI 患者梗死动脉位置、急性全冠状动脉闭塞与死亡率的关系。
Pol Arch Intern Med. 2017 Jun 30;127(6):401-411. doi: 10.20452/pamw.4018. Epub 2017 May 5.
7
Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.成功接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者中,心肌梗死溶栓治疗(TIMI)帧数与入院血糖值的关系。
Anadolu Kardiyol Derg. 2011 May;11(3):213-7. doi: 10.5152/akd.2011.055. Epub 2011 Mar 21.
8
Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patients.罪犯冠状动脉PCI术前血管造影的TIMI血流影响ST段抬高型心肌梗死患者的梗死面积和微血管阻塞。
J Cardiol. 2016 Mar;67(3):248-53. doi: 10.1016/j.jjcc.2015.05.008.
9
Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome.非ST段抬高型心肌梗死急性冠状动脉综合征患者中罪犯冠状动脉完全闭塞的发生率及影响
Egypt Heart J. 2021 Apr 7;73(1):36. doi: 10.1186/s43044-021-00160-x.
10
Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction.非ST段抬高型心肌梗死患者中罪犯冠状动脉完全闭塞的发生率及影响
Am J Cardiol. 2015 Feb 15;115(4):428-33. doi: 10.1016/j.amjcard.2014.11.023. Epub 2014 Nov 29.

引用本文的文献

1
Multidisciplinary approach for acute MI complicated by ventricular tachycardia, stent thrombosis, and multi-organ failure: A case report.急性心肌梗死合并室性心动过速、支架血栓形成和多器官功能衰竭的多学科治疗方法:一例报告。
Clin Case Rep. 2024 Jan 29;12(2):e8442. doi: 10.1002/ccr3.8442. eCollection 2024 Feb.

本文引用的文献

1
Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor?: JACC Review Topic of the Week.自发性/内源性纤维蛋白溶解状态受损是否为新的心血管危险因素?:JACC 本周综述主题。
J Am Coll Cardiol. 2019 Sep 10;74(10):1366-1375. doi: 10.1016/j.jacc.2019.07.030.
2
Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中,内源性纤维蛋白溶解受损是复发性心血管事件的预测因素:RISK PPCI 研究。
Eur Heart J. 2019 Jan 14;40(3):295-305. doi: 10.1093/eurheartj/ehy656.
3
Admission homocysteine is an independent predictor of spontaneous reperfusion and early infarct-related artery patency before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.入院时同型半胱氨酸是ST段抬高型心肌梗死患者在直接经皮冠状动脉介入治疗前自发再灌注和早期梗死相关动脉通畅的独立预测指标。
BMC Cardiovasc Disord. 2018 Jun 25;18(1):125. doi: 10.1186/s12872-018-0868-3.
4
Left Circumflex Coronary Artery as the Culprit Vessel in ST-Segment-Elevation Myocardial Infarction.左旋冠状动脉为ST段抬高型心肌梗死的罪犯血管
Tex Heart Inst J. 2017 Oct 1;44(5):320-325. doi: 10.14503/THIJ-16-5905. eCollection 2017 Oct.
5
Influence of angiographic spontaneous coronary reperfusion on long-term prognosis in patients with ST-segment elevation myocardial infarction.血管造影显示的自发性冠状动脉再灌注对ST段抬高型心肌梗死患者长期预后的影响。
Oncotarget. 2017 Jul 18;8(45):79767-79774. doi: 10.18632/oncotarget.19338. eCollection 2017 Oct 3.
6
Antithrombotic therapy for patients with STEMI undergoing primary PCI.ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗的抗栓治疗。
Nat Rev Cardiol. 2017 Jun;14(6):361-379. doi: 10.1038/nrcardio.2017.18. Epub 2017 Feb 23.
7
P2Y receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial.替格瑞洛和普拉格雷抑制P2Y受体对ST段抬高型心肌梗死患者溶栓治疗后的影响:来自SAMPA随机试验的分析
Int J Cardiol. 2017 Mar 1;230:204-208. doi: 10.1016/j.ijcard.2016.12.173. Epub 2016 Dec 27.
8
Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.溶栓状态受损可预测接受直接经皮冠状动脉介入治疗患者的不良心脏事件。
Thromb Haemost. 2017 Feb 28;117(3):457-470. doi: 10.1160/TH16-09-0712. Epub 2015 Dec 22.
9
Prehospital Clopidogrel Administration in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary PCI: Real-Life Experience From the Multicenter NRDES Registry.ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗时院前给予氯吡格雷:多中心NRDES注册研究的真实世界经验
J Invasive Cardiol. 2016 Jun;28(6):E56-8.
10
Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials.直接经皮冠状动脉介入治疗后梗死面积与结局的关系:10 项随机试验的患者水平分析。
J Am Coll Cardiol. 2016 Apr 12;67(14):1674-83. doi: 10.1016/j.jacc.2016.01.069.